
PPS
Pentosan Polysulfate Sodium
Potential Benefits
- FDA-approved for interstitial cystitis/painful bladder syndrome (Elmiron)
- Extensive veterinary use for osteoarthritis in horses and dogs with positive outcomes
- Research suggests glycosaminoglycan-restoring properties in cartilage
- May support joint health through anti-inflammatory and cartilage-protective mechanisms
- Studies indicate potential fibrinolytic and anti-thrombotic properties
Recommended Starting Dose
Oral: 100 mg three times daily (FDA-approved dose). Injectable: 2-3 mg/kg subcutaneously (veterinary-derived protocol)
Based on published research protocols. Not a prescription.
Dosing Protocol
Oral (FDA-approved for IC): 100 mg three times daily. Response is typically assessed after 3-6 months. Injectable protocols (adapted from veterinary use): 2-3 mg/kg subcutaneously once or twice weekly for 4-6 weeks, then monthly maintenance. Regular ophthalmologic monitoring is recommended with chronic use due to maculopathy risk.
DOSING INFORMATION DISCLAIMER: Any dosing information, protocols, or ranges discussed on this site are drawn from published research studies and clinical literature. They are presented for educational reference only and must not be used as self-medication guidance.
Expected Timeline
Phase 1
For interstitial cystitis, the FDA label notes that pain relief may take 3-6 months. Joint-related benefits in veterinary use are typically observed over 4-8 weeks of injectable treatment.
Research Status
The regulatory status of peptides can change at any time. Verify current FDA classification and legal status in your jurisdiction before seeking medical consultation about this compound.
Potential Side Effects
- Retinal pigmentary maculopathy associated with long-term oral use (important FDA warning)
- GI upset (nausea, diarrhea) with oral administration
- Headache
- Hair loss (reversible, reported in some patients)
- Bruising due to mild anticoagulant effects
- Injection site reactions with subcutaneous/IM administration
- Regular eye examinations recommended with long-term use
More in Recovery

BPC-157
Body Protection Compound-157
BPC-157 is a synthetic peptide derived from a protective protein found in human gastric juice. It consists of 15 amino acids and has been studied for its potential role in tissue repair, wound healing, and gut protection. Animal studies suggest it may accelerate healing of tendons, ligaments, muscles, and the gastrointestinal tract.

TB-500
Thymosin Beta-4
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide present in nearly all human and animal cells. It plays a role in cell migration, proliferation, and differentiation. Research has focused on its potential to promote tissue repair and reduce inflammation.

MGF
Mechano Growth Factor
MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is expressed in muscle tissue in response to mechanical stress (exercise) and damage. It plays a role in activating satellite cells, which are muscle stem cells critical for repair and hypertrophy. The synthetic version (PEG-MGF) includes polyethylene glycol modification for extended half-life.
Medical Disclaimer
EDUCATIONAL CONTENT ONLY: The peptide information presented on this page is compiled from published scientific literature, peer-reviewed research, and publicly available clinical data. It is provided strictly for educational purposes and does not constitute medical advice, an endorsement of any specific peptide, or a recommendation for treatment. Many peptides discussed on this site have not received FDA approval for human therapeutic use. Some may be under active regulatory review or subject to restrictions on compounding under FDA Section 503A and 503B frameworks. The regulatory status of individual peptides can change at any time. Readers should verify the current legal status of any peptide in their jurisdiction before pursuing further information or consultation. If you are considering peptide therapy, seek guidance from a licensed physician or healthcare provider who specializes in peptide-based treatments and operates within applicable federal and state regulations.